Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$124.75M
Total Bought:
$24.87M
Total Sold:
$66.75M
Net Transaction:
-$41.88M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Evommune, Inc.(EVMN)0589,005+589,005$0$10.08M8.08%+$10.08M
Contineum Therapeutics, Inc.CL A(CTNM)800,787800,7870$9.41M$9.15M7.34%-$256.3K
Eli Lilly and Company(LLY)9,3767,276-2,100$7.15M$7.82M6.27%+$665.5K
Shoulder Innovations, Inc.(SI)430,282492,435+62,153$5.40M$7.04M5.64%+$1.64M
UnitedHealth Group Incorporated(UNH)13,54513,595+50$4.68M$4.49M3.60%-$189.2K
Amgen Inc.(AMGN)10,34013,070+2,730$2.92M$4.28M3.43%+$1.36M
Johnson & Johnson(JNJ)15,30020,300+5,000$2.84M$4.20M3.37%+$1.36M
AbbVie Inc.(ABBV)14,80016,800+2,000$3.43M$3.84M3.08%+$411.8K
Vertex Pharmaceuticals Incorporated(VRTX)7,7158,005+290$3.02M$3.63M2.91%+$607.6K
Abbott Labs17,19823,498+6,300$2.30M$2.94M2.36%+$640.6K
Regeneron Pharmaceuticals, Inc.(REGN)3,9683,715-253$2.23M$2.87M2.30%+$636.4K
Intuitive Surgical, Inc.(ISRG)5,7504,850-900$2.57M$2.75M2.20%+$175.3K
Boston Scientific Corporation(BSX)22,12627,626+5,500$2.16M$2.63M2.11%+$474.0K
argenx SEADR(ARGX)3,8902,894-996$2.87M$2.43M1.95%-$435.4K
Danaher Corporation(DHR)10,57510,5750$2.10M$2.42M1.94%+$321.9K
Stryker Corporation(SYK)4,3006,550+2,250$1.59M$2.30M1.85%+$710.0K
Thermo Fisher Scientific Inc.(TMO)3,9003,9000$1.89M$2.26M1.81%+$367.1K
Merck & Co., Inc.(MRK)16,40021,400+5,000$1.39M$2.25M1.81%+$866.8K
Gilead Sciences, Inc.(GILD)19,55017,885-1,665$2.17M$2.20M1.76%+$25.2K
Insmed Incorporated(INSM)13,42511,182-2,243$1.93M$1.95M1.56%+$12.8K
DexCom, Inc.(DXCM)20,70028,700+8,000$1.39M$1.90M1.53%+$511.9K
Vera Therapeutics, Inc.CL A(VERA)30,18836,858+6,670$877.3K$1.87M1.50%+$989.2K
Structure TherapeuticsADR221,87223,872-198,000$6.21M$1.66M1.33%-$4.55M
BioNTech SEADR(BNTX)17,66017,218-442$1.74M$1.64M1.31%-$102.5K
Edwards Lifescience15,00017,250+2,250$1.17M$1.47M1.18%+$304.0K
AstraZeneca PLCADR(AZN)18,75015,232-3,518$1.44M$1.40M1.12%-$38.2K
Summit Therapeutics Inc.(SMMT)74,07079,625+5,555$1.53M$1.39M1.12%-$137.6K
Arcus Biosciences, Inc.(RCUS)368,07056,945-311,125$5.01M$1.36M1.09%-$3.65M
Syndax Pharmaceuticals, Inc.(SNDX)79,43061,200-18,230$1.22M$1.29M1.03%+$63.8K
Tarsus Pharmaceuticals, Inc.(TARS)18,40514,740-3,665$1.09M$1.21M0.97%+$113.1K
Alnylam Pharmaceuticals, Inc.(ALNY)3,2732,990-283$1.49M$1.19M0.95%-$303.5K
Rapport Therapeutics, Inc.(RAPP)43,48038,925-4,555$1.29M$1.18M0.95%-$110.4K
Cogent Biosciences, Inc.(COGT)032,685+32,685$0$1.16M0.93%+$1.16M
Mineralys Therapeutics, Inc.(MLYS)33,88531,625-2,260$1.28M$1.15M0.92%-$137.2K
Trevi Therapeutics, Inc.(TRVI)105,95084,255-21,695$969.4K$1.05M0.85%+$85.4K
Roivant Sciences Ltd.SHS(ROIV)50,00745,347-4,660$756.6K$984.0K0.79%+$227.4K
Tectonic Therapeutic, Inc.(TECX)192,77042,255-150,515$3.02M$881.4K0.71%-$2.14M
Ventyx Biosciences1,107,26796,945-1,010,322$3.44M$875.4K0.70%-$2.57M
BridgeBio Pharma, Inc.(BBIO)13,65011,170-2,480$709.0K$854.4K0.68%+$145.4K
United Therapeutics Corporation(UTHR)7651,723+958$320.7K$839.5K0.67%+$518.8K
Boundless Bio, Inc.(BOLD)678,574678,5740$834.6K$814.3K0.65%-$20.4K
BeOne Medicines AGADR(ONC)7,2012,665-4,536$2.45M$809.7K0.65%-$1.64M
RadNet, Inc.(RDNT)10,00011,000+1,000$762.1K$784.9K0.63%+$22.8K
ArriVent BioPharma, Inc.(AVBP)39,23538,255-980$723.9K$769.7K0.62%+$45.8K
uniQure N.V.SHS(QURE)30,74030,585-155$1.79M$731.9K0.59%-$1.06M
Ascendis Pharma A/SADR(ASND)3,6013,254-347$715.9K$693.9K0.56%-$22.0K
LENZ Therapeutics, Inc.(LENZ)042,500+42,500$0$680.0K0.55%+$680.0K
Pfizer Inc.(PFE)77,15027,150-50,000$1.97M$676.0K0.54%-$1.29M
Inspire Medical Systems, Inc.(INSP)07,200+7,200$0$664.1K0.53%+$664.1K
Ionis Pharmaceuticals, Inc.(IONS)9,2058,365-840$602.2K$661.8K0.53%+$59.6K
Immatics N.V.SHS(IMTX)560,49463,015-497,479$4.78M$661.7K0.53%-$4.11M
Hinge Health, Inc.CL A(HNGE)11,20614,206+3,000$550.0K$659.9K0.53%+$109.9K
BioMarin Pharmaceutical Inc.(BMRN)25,03010,880-14,150$1.36M$646.6K0.52%-$709.0K
Alignment Healthcare, Inc.(ALHC)54,50031,500-23,000$951.0K$622.1K0.50%-$328.9K
Amicus Therapeutics
COM
119,10543,300-75,805$938.5K$616.6K0.49%-$322.0K
Privia Health Group, Inc.(PRVA)36,50026,000-10,500$908.9K$616.5K0.49%-$292.4K
Carlsmed, Inc.(CARL)047,700+47,700$0$589.1K0.47%+$589.1K
PTC Therapeutics, Inc.(PTCT)8,5357,715-820$523.8K$586.0K0.47%+$62.2K
Omada Health, Inc.(OMDA)27,50036,500+9,000$608.0K$576.0K0.46%-$32.1K
Nektar Therapeutics(NKTR)013,485+13,485$0$570.1K0.46%+$570.1K
Kura Oncology, Inc.(KURA)395,87254,110-341,762$3.50M$562.2K0.45%-$2.94M
Neurocrine Biosciences, Inc.(NBIX)2,9602,675-285$415.5K$379.4K0.30%-$36.1K
Biogen Inc.(BIIB)2,3752,155-220$332.7K$379.3K0.30%+$46.6K
Cytokinetics, Incorporated(CYTK)10,2235,893-4,330$561.9K$374.4K0.30%-$187.4K
Jazz Pharmaceuticals plcSHS USD(JAZZ)2,2442,049-195$295.8K$348.3K0.28%+$52.6K
ARS Pharmaceuticals, Inc.(SPRY)81,78529,803-51,982$821.9K$347.2K0.28%-$474.7K
Royalty Pharma plcCL A(RPRX)9,2808,470-810$327.4K$327.3K0.26%-$117
Illumina, Inc.(ILMN)2,7272,472-255$259.0K$324.2K0.26%+$65.2K
Axsome Therapeutics, Inc.(AXSM)1,0201,740+720$123.9K$317.8K0.25%+$193.9K
Incyte Corporation(INCY)3,0302,750-280$257.0K$271.6K0.22%+$14.6K
Tempus AI, Inc.CL A(TEM)3,7604,500+740$303.5K$265.7K0.21%-$37.7K
Madrigal Pharmaceuticals, Inc.(MDGL)730352-378$334.8K$205.0K0.16%-$129.8K
ORIC Pharmaceuticals, Inc.(ORIC)328,65522,480-306,175$3.94M$183.9K0.15%-$3.76M
Moderna, Inc.(MRNA)5,6005,005-595$144.6K$147.6K0.12%+$3.0K
Anaptysbio Inc194,4850-194,485$5.96M$0—-$5.96M
Bicara Therapeutics266,4950-266,495$4.21M$0—-$4.21M
Bristol-Myers Squibb Company(BMY)10,8000-10,800$487.1K$0—-$487.1K
The Cigna Group(CI)1,8000-1,800$518.9K$0—-$518.9K
Instil Bio, Inc.(TIL)161,3800-161,380$2.88M$0—-$2.88M
MBX Biosciences, Inc.(MBX)194,8980-194,898$3.41M$0—-$3.41M
MoonLake ImmunotherapeuticsCL A(MLTX)9560-956$6.9K$0—-$6.9K
Palvella Therapeutics, Inc.(PVLA)49,1150-49,115$3.08M$0—-$3.08M
Spdr Series TrustS P BIOTECH
ST STR SP BIOT
34,0000-34,000$3.41M$0—-$3.41M
Solid Biosciences633,0520-633,052$3.91M$0—-$3.91M
Vaxcyte, Inc.(PCVX)4,2050-4,205$151.5K$0—-$151.5K
Zai Lab LimitedADR(ZLAB)12,5900-12,590$426.7K$0—-$426.7K
Zenas BioPharma, Inc.(ZBIO)152,0250-152,025$3.37M$0—-$3.37M
Merus B V11,5450-11,545$1.09M$0—-$1.09M
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q4 2025 | TickerTrail